Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
The DOI matches its Crossref record; 32 of the 34 references it cites were found in a registry or an index.
Abstract
Background There have been few reports on hepatocellular carcinoma (HCC) in nonalcoholic steatohepatitis (NASH) and the natural history of NASH. Accordingly, we assessed the clinical features of HCC in NASH, the risk factors for HCC, and natural history of NASH with advanced fibrosis. Patients and methods There were 34 NASH patients with HCC and 348 NASH patients without HCC. To clarify the clinical features of NASH patients with HCC and to determine the risk factors for HCC, we compared NASH patients with HCC with those without HCC. Univariate and multivariate logistic regression models were used for statistical analysis. A prospective cohort study of the outcomes of 137 NASH with advanced fibrosis was started in 1990. The impact of baseline risk factors on the development of HCC and survival was evaluated by Cox regression analysis. Results In total, 88% of patients with HCC had advanced fibrosis, with a median age of 70 years. Older age, low level of AST, low grade of histological activity, and advanced stage of fibrosis were risk factors for HCC. A prospective cohort study showed that the 5-year cumulative incidence of HCC was 7.6%, and the 5-year survival rate was 82.8%. HCC was the leading cause of death. Conclusions The present study confirmed that older age and advanced fibrosis were important risk factors for HCC, and that HCC was the major cause of mortality in NASH patients with advanced fibrosis. Regular screening for HCC is thus extremely important for NASH patie…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like HCC caused by other risk factors, NAFLD-induced HCC is predominantly diagnosed in males, but at older ages and earlier disease stages (Hashimoto et al., 2009).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Hashimoto et al., 2009
In the citing paper
“at an age correspondent to the median age of spontaneous HCC diagnosis at 67–72 years in humans (Hashimoto et al., 2009; Kunstyr and Leuenberger, 1975; Yasui et al., 2011)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Hashimoto et al., 2009
In the citing paper
“NASH and advanced fibrosis increase HCC risk by 15 and 25 folds in humans, respectively (Guzman et al., 2008; Hashimoto et al., 2009).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Hashimoto et al., 2009
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 9×
“The increasing numbers of cases of HCC resulting from liver disease of unknown cause probably contribute to HCC in NASH.”
MethodInfluentialOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415 · cited 1×
“HCC is the fi fth most common cancer worldwide and the third most common cause of cancer mortality.(24) According to the most recent nationwide Japanese registration data, primary liver cancer ranked third for men and fi fth for women as a cause of death from malignant neoplasm.”
BackgroundClinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089 · cited 1×
“HCC was diagnosed histologically or by detection of consistent fi ndings on at least two radiologic modalities.(23) During the follow-up period, weight was mainly controlled by diet and exercise in obese patients.”
MethodNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · cited 1×
“Steatosis was graded as mild to severe: mild (affecting 10%–29% of hepatocytes); moderate (30%–69% of hepatocytes); or severe (>70% of hepatocytes).(21,22)”
BackgroundLong-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302 · cited 1×
“Another important fi nding of this study was that no patient among the NASH patients with advanced fi brosis died of heart disease, although several reports have indicated that NAFLD and NASH are risk factors for cardiovascular and cerebrovascular disease.(16) It is possible that patients with cardiovascular events ar…”
BackgroundNonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Nonalcoholic Steatohepatitis: Definition and Pathology
Brunt, E. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12925 · Cited by 911
Our new president—Jon I. Isenberg, M.D
Boland, C. R., & Yamada, T. (2001) · Gastroenterology · doi:10.1053/gast.2001.24057 · Cited by 629
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603
Inoue, M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1871 · Cited by 561
Sanyal, A. J., Banas, C., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Heuman, D., Coterrell, A., Fisher, R. A., et al. (2006) · Hepatology · doi:10.1002/hep.21103 · Cited by 522
Molecular Virology of Hepatitis B Virus
Locarnini, S. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828672 · Cited by 515
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
Ratziu, V., Bonyhay, L., Di Martino, V., Charlotte, F., Cavallaro, L., Sayegh-Tainturier, M.-H., Giral, P., Grimaldi, A., Opolon, P., & Poynard, T. (2002) · Hepatology · doi:10.1053/jhep.2002.33324 · Cited by 464
Jimba, S., Nakagami, T., Takahashi, M., Wakamatsu, T., Hirota, Y., Iwamoto, Y., & Wasada, T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01582.x · Cited by 455 · cited 2×
“In Japan, annual health checks have begun to show 10%–30% of adults being diagnosed as having NAFLD.(3,4) Based on the prevalence of NAFLD, the prevalence of nonalcoholic steatohepatitis (NASH) is estimated to be 1%–3% of Japanese adults.”
BackgroundKojima, S.-I., Watanabe, N., Numata, M., Ogawa, T., & Matsuzaki, S. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1178-8 · Cited by 455 · cited 2×
“In Japan, annual health checks have begun to show 10%–30% of adults being diagnosed as having NAFLD.(3,4) Based on the prevalence of NAFLD, the prevalence of nonalcoholic steatohepatitis (NASH) is estimated to be 1%–3% of Japanese adults.”
BackgroundLong–Term Outcomes of Cirrhosis in Nonalcoholic Steatohepatitis Compared With Hepatitis C
Hui, J. M., Kench, J. G., Chitturi, S., Sud, A., Farrell, G. C., Byth, K., Hall, P., Khan, M., & George, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50320 · Cited by 437
Obesity and hepatocellular carcinoma
Caldwell, S. H., Crespo, D. M., Kang, H. S., & Al-Osaimi, A. M. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.021 · Cited by 396
Amarapurkar, D. N., Hashimoto, E., Lesmana, L. A., Sollano, J. D., Chen, P., Goh, K., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05042.x · Cited by 395 · cited 2×
“Recently, lifestyle-related diseases (metabolic syndrome) such as diabetes mellitus, hypertension, and hyperlipidemia have become a leading public health problem because of their dramatic increase in both Western countries and Asia.1,2 Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic sy…”
BackgroundSelf-citationHepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Shimada, M., Hashimoto, E., Taniai, M., Hasegawa, K., Okuda, H., Hayashi, N., Takasaki, K., & Ludwig, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00099-5 · Cited by 356
Self-citationChitturi, S., Farrell, G. C., Hashimoto, E., Saibara, T., Lau, G. K., Sollano, J. D., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05001.x · Cited by 312 · cited 1×
“The diagnosis of NASH was based on the following criteria: (1) detection of steatohepatitis on liver biopsy, ( 2 ) intake of less than 100 g ethanol per week (as confi rmed by the attending physician and family members who were in close contact with the patient), and (3) appropriate exclusion of other liver diseases (…”
MethodSelf-citationNon-alcoholic Steatohepatitis and Cancer
Bugianesi, E. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.006 · Cited by 245
(2002) · Gastroenterology · doi:10.1053/gast.2002.36569 · Cited by 193
Ohki, T., Tateishi, R., Sato, T., Masuzaki, R., Imamura, J., Goto, T., Yamashiki, N., Yoshida, H., Kanai, F., Kato, N., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.012 · Cited by 160
Natural history of nonalcoholic steatohepatitis.
Liou, I. W., & Kowdley, K. V. (2006) · PubMed · doi:10.1097/01.mcg.0000168644.23697.31 · Cited by 146
Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH
Yoshioka, Y., Hashimoto, E., Yatsuji, S., Kaneda, H., Taniai, M., Tokushige, K., & Shiratori, K. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-004-1475-x · Cited by 119
Self-citationThe characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease
Hashimoto, E., Yatsuji, S., Kaneda, H., YOSHIOKA, Y., Taniai, M., Tokushige, K., & Shiratori, K. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.007 · Cited by 116
Self-citationAssessing the outcome of nonalcoholic steatohepatitis? It's time to get serious†‡
Ratziu, V., & Poynard, T. (2006) · Hepatology · doi:10.1002/hep.21391 · Cited by 69
Hashimoto, E., Taniai, M., Kaneda, H., Tokushige, K., Hasegawa, K., Okuda, H., Shiratori, K., & Takasaki, K. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2004.tb03237.x · Cited by 37
Self-citationHashimoto, E., Taniai, M., Kaneda, H., Tokushige, K., Hasegawa, K., Okuda, H., Shiratori, K., & Takasaki, K. (2004) · Alcoholism: Clinical & Experimental Research · doi:10.1097/01.alc.0000133547.70803.83 · Cited by 36
Self-citationAtsumi, Y., Yatsuji, S., Torii, N., Tokushige, K., Hashimoto, E., Yamamoto, M., & Shiratori, K. (2007) · Kanzo · doi:10.2957/kanzo.48.604 · Cited by 5
Self-citation
Research works printed but not linked: 3
- Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3–20.
- Journal of Health and Welfare Statistics. Health and Welfare Statistics Association Japan; 2004.
- The nationwide report registered every 2 years by the Liver Cancer Study Group of Japan (in Japanese with English abstract). Kanzo 2007;48:117–140.
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
“Specifically, a study of Mexican Mestizo patients with CC shows that the prevalence of the metabolic syndrome was 500% higher than in patients without CC.112 In addition to the indirect link between CC and NASH, the association between NASH and hepatocellular carcinoma (HCC) provides another type of indirect evidence…”
InfluentialOmata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
“[58] examined 34 cases of NASH-related HCC and found that there was a prevalence of advanced age, male sex, obesity, and type 2 DM; 12% of the patients had stage 1 or 2 fibrosis, and 88% had advanced fibrosis (stage 3–4).”
BackgroundChalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Metadata
- Authors
- Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., Tokushige, K., & Shiratori, K.
- Affiliations
- Tokyo Women's Medical University (JP)
- Venue
- Journal of Gastroenterology
- Published
- 2009-01
- Volume
- 44
- Issue
- S19
- Pages
- 89-95
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2079163236
- Cited by
- 308
- References
- 34
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 14 · 2020: 15 · 2019: 14 · 2018: 19 · 2017: 16 · 2016: 19 · 2015: 26 · 2014: 31 · 2013: 32 · 2012: 27
- FWCI
- 19.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- hepatocellular carcinoma, nonalcoholic steatohepatitis, advanced liver fibrosis, HCC risk factors, HCC incidence, HCC mortality, HCC screening, age, AST, histological activity
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Child, Fatty Liver, Female, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Male, Middle Aged, Prospective Studies, Risk Factors, Cohort Studies, Survival Rate, Logistic Models, Proportional Hazards Models, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.